Tag Archives: U.S.

U.S. government gives Moderna Inc $472 million for coronavirus vaccine development

A view of Moderna headquarters on May 08, 2020 in Cambridge, Massachusetts. Moderna was given FDA approval to continue to phase 2 of Coronavirus (COVID-19) vaccine trials with 600 participants. (Photo by Maddie Meyer/Getty Images) Moderna Inc., a biotech company that develops pharmaceuticals, received $ 472 million award from the federal Biomedical Advanced Research and… Read More »

Coronavirus cases surge in U.S. and Brazil as Germany reports more outbreaks, but markets don’t seem worried

People enjoy the beach in Leme, south of Rio de Janeiro, Brazil, on June 21, 2020 during the Covid-19 coronavirus pandemic. CARL DE SOUZA A surge in coronavirus cases in the U.S. and Brazil, and further outbreaks in Germany — where the reproduction rate of the disease has risen substantially — are concerning global health experts,… Read More »

U.S. coronavirus deaths top 110,000 as cases approach 2 million: Reuters tally

A medical worker checks the temperature of an arriving guest during the reopening of Bellagio hotel-casino, closed since March 16, 2020 as part of steps to slow the spread of the coronavirus disease (COVID-19), in Las Vegas, Nevada, U.S. June 4, 2020. REUTERS/Steve Marcus (Reuters) – The novel coronavirus has killed more than 110,000 people… Read More »

Boston Sci’s DIRECTSENSE Ablation Monitoring Tech Coming to U.S.

Boston Scientific is releasing in the United States its DIRECTSENSE Technology for live monitoring of cardiac tissue during radiofrequency ablation procedures. The capability is designed for use on the company’s RHYTHMIA HDx Mapping System along with the INTELLANAV MiFi Open-Irrigated ablation catheter and it works by measuring the change in electrical impedance of the tissue… Read More »

AbbVie touts Humira defense strategy abroad as a positive sign for forthcoming U.S. battle

AbbVie’s strength has long been tied to the performance of megablockbuster Humira, which is facing an existential threat as U.S. copycats creep closer. Despite a “more aggressive” than expected biosimilar challenge abroad, AbbVie believes its defense strategy—and lessons learned—will help it weather the storm. In an earnings call with analysts Friday, AbbVie CEO Rick Gonzalez touted the drugmaker’s… Read More »